Verici Dx plc (LON:VRCI – Get Free Report) shares traded up 11.8% on Wednesday . The stock traded as high as GBX 0.95 and last traded at GBX 0.86. 16,085,123 shares changed hands during mid-day trading, an increase of 683% from the average session volume of 2,053,311 shares. The stock had previously closed at GBX 0.77.
Verici Dx Trading Down 5.6%
The stock has a market capitalization of £11.43 million, a price-to-earnings ratio of -0.26 and a beta of 1.59. The company’s 50-day moving average is GBX 0.70 and its 200-day moving average is GBX 0.89. The company has a quick ratio of 8.49, a current ratio of 4.54 and a debt-to-equity ratio of 4.64.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- CRWD Stock Hits Key Inflection Point Ahead of Earnings
- Canadian Penny Stocks: Can They Make You Rich?
- Rigetti’s Q3 Miss Reveals Quantum Funding and Timing Pressures
- Health Care Stocks Explained: Why You Might Want to Invest
- Monolithic Power Surges in 2025—Time to Buy or Hold?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
